Table 2.
Phototherapy | No Phototherapy | p-value | |
---|---|---|---|
N(%) | N(%) | ||
Outcomes by 18 months | |||
Allergen sensitization | 14 (13.5) | 98 (13.6) | 0.9 |
Eczema | 27 (25.7) | 152 (20.3) | 0.2 |
Rhinitis | 13 (14.6) | 119 (19.0) | 0.4 |
Early onset of wheeze and use of nebulizer/inhaler | 7 (7.8) | 60 (10.0) | 0.7 |
Outcomes by 36 months | |||
Allergen sensitization | 22 (21.2) | 172 (23.8) | 0.6 |
Eczema | 29 (27.6) | 180 (24.0) | 0.5 |
Rhinitis | 31 (34.8) | 221 (35.2) | 0.9 |
Early onset of wheeze and use of nebulizer/inhaler | 17 (14.9) | 158 (19.5) | 0.3 |
Outcomes by 60 months | |||
Allergen sensitization | 33 (35.5) | 232 (34.8) | 0.9 |
Eczema | 31 (29.8) | 192 (26.0) | 0.4 |
Rhinitis | 35 (39.8) | 245 (39.9) | 0.9 |
Early onset of wheeze and use of nebulizer/inhaler | 16 (17.0) | 150 (22.8) | 0.2 |